department of neurology  
  Telephone: 212 305-1710 || Address: The Neurological Insitute of New York, 710 West 168th Street, 6th Floor, New York, NY 10032  
 
 
 

ITT: Intraventricular Hemorrhage Thrombolysis (r-tPA) Trial




» Previous Study || » Next Study
» back to Research

Intraventricular hemorrhage (IVH) occurs in approximately 22,000 people every year in the United States. Previous studies have shown that IVH is a significant and independent contributor to morbidity and mortality. Unfortunately, there is currently no satisfactory treatment of IVH.

The purpose of the

ITT

is to assess the efficacy of intraventricular injections of recombinant tissue plasminogen activator (r-tPA) in improving the outcomes of external ventricular drainage in patients with IVH.

Eligible Participants

(1) ages 18 years – 75 years
(2) More than 12 hours post bleed
(3) Hematoma size stable by CT scan
(4) Post-IVH catheter CT scan
(5) Able to begin study within 24 hours of bleed




About Us || Our Doctors || Resources || Research || In The News || Contact Us || Sitemap
Copyright © 2008 Division of Stroke, Department of Neurology, Columbia University Medical Center, New York || The Neurological Institute of New York || Affiliated with New York-Presbyterian Hospital || Last updated: January 26, 2012 | Comments